Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical and Experimental Dermatology|July 3, 2014
Multiple halo naevi associated with tocilizumabK Kuet, M GoodfieldThe British Journal of Dermatology|August 1, 1995
Methotrexate for the treatment of severe mucocutaneous lupus erythematosusW W Bottomley, M GoodfieldThe Journal of Dermatological Treatment|February 3, 2004
Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE)M Goodfield, K Davison, K BowdenThe Journal of Investigative Dermatology|September 1, 1989
Reactive hyperemic responses in systemic sclerosis patients and healthy controlsM Goodfield, A Hume, N RowellThe Journal of Dermatological Treatment|February 3, 2004
Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasisM Goodfield, S Kownacki, J Berth-JonesDermatology (Basel, Switzerland)|November 13, 2004
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trialJ-P Ortonne, R Kaufmann, M Lecha, et al.Clinical and Experimental Dermatology|October 31, 2009
Photochemotherapy for systemic sclerosis: effect on clinical and molecular markersN Usmani, A Murphy, D Veale, et al.Clinical and Experimental Dermatology|August 14, 2008
Photochemotherapy for localized morphoea: effect on clinical and molecular markersN Usmani, A Murphy, D Veale, et al.The Journal of Investigative Dermatology|June 1, 1989
Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser--Doppler flowmetry and immunocytochemical techniquesS M Hull, M Goodfield, E J Wood, et al.Journal of Autoimmunity|November 6, 1998
Does the CDR3 of the heavy chain determine the specificity of autoantibodies in systemic lupus erythematosus?Z A Yazici, M Behrendt, M Goodfield, et al.Pageof 4